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Abstract
Background: The chitinase-like protein YKL-40 plays a major role in inhibiting the inflammasome. Deregulation of
inflammasome activation is emerging as a key modulator of pathologic airway inflammation in patients with
asthma. We determined whether cis-expression quantitative trait loci (eQTLs) of the gene that encodes YKL-40,
chitinase 3-like 1 (CHI3L1), are involved in the onset of asthma or in specific asthma phenotypes.
Methods: This case-control study, which was conducted at the University of Tsukuba, Japan, included a total of
2709 adults from the Tsukuba genome-wide association study (GWAS) cohort (734 healthy volunteers and 237
asthma patients), the Tsukuba replication cohort (375 healthy adult volunteers and 381 adult asthma patients), and
the Hokkaido replication cohort (554 healthy adult volunteers and 428 adult asthma patients). Among 34 cis-eQTLs
in CHI3L1 in the lung, rs946261 was associated with adult asthma in these Japanese cohorts. The genetic impact of
rs946261 on asthma was also examined according to the age at onset and adult asthma clusters.
Results: In the Tsukuba GWAS cohort, the C allele at rs946261 was significantly associated with reduced
expression of CHI3L1 mRNA in the lung and with development of asthma (odds ratio (OR) 1.27; P = 0.036). The
association was also observed following analysis of the three Japanese cohorts (OR 1.16; P = 0.013). A stronger
association was found with late-onset asthma that developed at 41 years of age or later (OR 1.24; 95% confidence
interval (CI) 1.07–1.45; P = 0.0058) and with a specific asthma phenotype characterized by late onset, less atopy,
and mild airflow obstruction (OR 1.29; 95% CI 1.03–1.61; P = 0.027).
Conclusions: The genotype consisting of the cis-eQTL allele that reduces expression of CHI3L1 was specifically
associated with late-onset adult asthma. Given the important role of YKL-40 in many pathophysiological
processes, including cell growth, migration, chemotaxis, reorganization, and tissue remodeling, it may be involved
in an important pathogenic role in the establishment of inflammation and remodeling in asthmatic airways. Our
findings may indicate the presence of a specific endotype related to exaggerated activation of YKL-40 in the
pathogenesis of late-onset adult asthma.
Keywords: Chitinase 3-like 1 (CHI3L1), YKL-40, Expression quantitative trait loci (eQTLs), Asthma, Genetics, Late-onset
adult asthma
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Background
YKL-40 is a prototypic mammalian chitinase-like pro-
tein. YKL-40 is expressed by multiple cell types in the
lung, such as macrophages, neutrophils, and epithelial
cells [1, 2]. This protein was increased in the serum from
patients with community-acquired pneumonia severe
enough to necessitate hospitalization [3]. Functionally,
YKL-40 plays a crucial role in the regulation of response
to bacterial infections by increasing the killing of bac-
teria, regulation of the correctness and strength of in-
nate immune responses to bacteria, and facilitation of
acquisition of adaptive immunity, healing, and repair [4].
Expression of YKL-40 is correlated with airway ob-
struction and assessment of airway remodeling including
the thickness of the bronchial wall [5, 6]. Extracellular
YKL-40 participates in inhibition of the inflammasome,
followed by a decrease in the proinflammatory cytokine
interleukin (IL)-1β [4]. However, the precise role of
YKL-40 in asthma has not been clarified. Overactivation
of the inflammasome is a new concept regarding modu-
lation of pathologic airway inflammation in patients with
asthma [7, 8]. Thus, we hypothesized that altered ex-
pression of YKL-40 may result in inappropriate inflam-
masome activation, and may thus play an important role
in chronic pulmonary diseases such as asthma.
Chitinase 3-like 1 (CHI3L1), which is located on
chromosome 1q31-q32 and includes 10 exons, encodes
YKL-40 [9]. The rs4950928 polymorphism in CHI3L1, as
shown in a genome-wide association study (GWAS), is
associated with asthma risk, YKL-40 levels in blood, and
respiratory function [10]. Other CHI3L1 polymorphisms
may play a role in development of asthma and are dis-
tinctly related to steroid-insensitive, non-T-helper cell
type 2 chronic inflammation [11]. However, the results
are inconsistent because of small sample sizes in previ-
ous studies, the presence of multiple causal variants at
the loci, and differences in ethnicity, smoking exposure,
and age. A systematic meta-analysis of five studies found
no significant association [12].
Studying differences in gene expression can increase
statistical power and improve interpretation of GWASs
of susceptibility to complex diseases [13, 14]. Thus, we
here examined the genetic impact of alleles associated
with altered gene expression at expression quantitative
trait loci (eQTLs) of CHI3L1 on the development of
asthma by performing a candidate gene case-control as-
sociation study on 2709 adults from three independent
Japanese populations, paying particular attention to the
disease phenotypes.
Methods
Ethics statement
This study was approved by the Human Genome
Analysis and Epidemiology Research Ethics Committee
of the University of Tsukuba as well as by the Human
Genome/Gene Analysis Research Ethics Review
Committees of the Tsukuba Medical Center and of
RIKEN. Written informed consent was obtained from
each participant before the study, which was per-
formed in accordance with the principles of the Dec-
laration of Helsinki.
Study participants
The Tsukuba GWAS cohort includes 971 Japanese indi-
viduals (734 healthy participants and 237 asthma pa-
tients) [15–17]. All individuals in this cohort underwent
genome-wide single-nucleotide polymorphism (SNP)
analysis [15]. To establish this cohort, healthy adults
without respiratory diseases were recruited from among
individuals who underwent an annual health exam at the
Tsukuba Medical Center [18]. Patients with asthma,
which was diagnosed by specialists in pulmonary medi-
cine according to the criteria of the Japanese Society of
Allergology [19], were recruited from the University of
Tsukuba Hospital [20]. To eliminate the environmental
effects of smoking in the present study, we excluded vol-
unteers who smoked more than 10 pack-years. The mul-
tiple allergen simultaneous test-26 chemiluminescent
assay was used to quantitate the levels of specific serum
IgE antibodies [21]. Atopy was defined as a positive re-
sponse (> 1.00 lumicount) to one or more of 14 common
inhaled allergens.
Two independent Japanese cohorts, the Tsukuba and
Hokkaido replication cohorts, were used to confirm the
findings in the Tskuba GWAS cohort. Participants with
a smoking history as described above were excluded.
The Tsukuba replication cohort includes 375 healthy
adult volunteers and 381 adults with asthma. The
healthy adults in this cohort were also recruited from in-
dividuals who underwent an annual health exam at the
Tsukuba Medical Center [18]. Individuals with asthma
were recruited from the University of Tsukuba Hospital
and underwent phenotypic and genetic analyses related
to asthma [22]. The Hokkaido replication cohort in-
cludes 554 healthy adult volunteers and 428 adults with
asthma who were recruited from Hokkaido University
Hospital [15]. The original intent of studying these two
cohorts was to determine genes that were associated
with susceptibility to asthma in Japan.
Search for eQTLs in CHI3L1
In complex diseases such as asthma, eQTLs play a sig-
nificant role in trait associations in pathologically related
tissues and explain a large proportion of heritability; ex-
pression of asthma-related genes is cis-regulated by
asthma risk alleles in TSLP, GSDMB, IL33, HLA-DQB1,
C11orf30, DEXI, CDHR3, HCG22, HAS2, and ZBTB10
[16, 17, 23]. Thus, we first searched the GTEx Portal
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database (https://gtexportal.org/home/) for cis-eQTLs in
CHI3L1 in the lung that are located within 1Mb of the
transcription start site of CHI3L1.
Genotyping
An automated DNA extraction system (QuickGene-610
L; Fujifilm, Tokyo, Japan) was used to isolate genomic
DNA from whole blood samples. Samples from all indi-
viduals in the Tsukuba discovery cohort were used for
GWAS genotyping, which was performed with Illumina
HumanHap 550 k v3/610-Quad BeadChips (Illumina,
San Diego, CA, USA) [15]. Rs946261 genotypes were de-
termined in both replication cohorts using TaqMan
allele-specific amplification (Applied Biosystems, Foster
City, CA, USA).
Statistical analysis
We initially used the Tsukuba GWAS data to examine
the genetic effects of CHI3L1 as one of the promising
asthma candidate genes (ie, those previously associated
in two or more non-Japanese cohorts) in Japanese popu-
lations. Also, given the ethnic difference in the LD pat-
tern in the CHI3L1 region, we tried a replication at the
gene level but not at the SNP level. Six eQTLs that res-
ide within 1Mb of the transcription start site of CHI3L1
were examined with logistic regression modeling for as-
sociations with asthma. As only rs946261 was associated
with the presence of asthma in the Tsukuba GWAS co-
hort, this SNP was further genotyped in the Tsukuba
and Hokkaido replication cohorts, and the combined
results from the three independent cohorts were ana-
lyzed by adjusting for the cohort in the logistic
regression model.
The age at onset of asthma was reported by each pa-
tient. To obtain the most accurate age at onset of asthma
as possible, patients were questioned about dyspnea,
wheezing, or coughing before the age of 18 years. When
asthma onset was uncertain, the age at which the patient
experienced the earliest respiratory symptoms was consid-
ered the age at onset of asthma symptoms [24].
To further examine the relationship between the age
at onset of asthma and the genetic effects of the
loss-of-function eQTL allele, we performed survival ana-
lyses of all the participants, with age at onset of asthma
as the primary outcome. The Kaplan–Meier method was
used to visualize the time required for development of
asthma in subgroups stratified according to CHI3L1
genotypes. This method was used to plot the proportion
of the population that was asthma-free based on the in-
dividual’s age at the time of evaluation. A multivariate
Cox proportional hazard regression model with the co-
hort and smoking index as covariates was used to
estimate the hazard ratio (HR) of the effect of CHI3L1
genotypes for the risk of asthma, which was reported
with the 95% confidence interval (CI).
We also assessed the effect of the CHI3L1 genotype
using previously determined clusters of adult asthma
classified by a multinomial logistic regression model to
predict the probabilities of the different possible out-
comes of specific phenotypes. In this previous study
[22], we performed a two-step cluster analysis of 880
adult Japanese individuals with asthma and identified six
phenotypes using eight variables: age, sex, age at disease
onset, smoking status, total levels of serum IgE, percent
of predicted forced expiratory volume in the first second
(%FEV1), ratio of FEV1 to forced vital capacity (FVC),
and specific IgE responsiveness to common inhaled al-
lergens. The six phenotypes we identified were cluster A:
older age at asthma onset, no airflow obstruction; cluster
B: childhood asthma onset, no or mild airflow obstruc-
tion; cluster C: childhood asthma onset, long duration of
asthma, and moderate or severe airflow obstruction;
cluster D: older age at asthma onset, severe airflow ob-
struction; cluster E: intermediate age at asthma onset,
no airflow obstruction; and cluster F: older age at onset,
mild or moderate airflow obstruction. The two strongest
variables for differentiation of these clusters were age at
asthma onset and %FEV1. We then established a classifi-
cation and regression tree (CART) model using these
two variables [22]. In the current study, using this CART
model, we assigned each adult patient with asthma to
one of these clusters, with the result that 968 adult pa-
tients with asthma (574 in the Tsukuba cohort and 394
in the Hokkaido cohort) had the data for age at asthma
onset and %FEV1, and were assigned to one of the six
clusters. Among these 968 patients, 605 patients with
asthma had been studied in the previous study [22], and
the additional 363 patients with asthma were collected
in the same geographic regions as the 605 patients. No
differences in the clinical characteristics were found be-
tween the 605 and the 363 patients with adult asthma
(data not shown). In addition, 1663 healthy adults (1109
in the Tsukuba cohort and 554 in the Hokkaido cohort)
were included in the analysis as a seventh group and
used as a reference in the multinomial model.
In the present study, considering that functional
SNPs in the biological candidate may not yield sig-
nificant p-values after correction for multiple testing
but may replicate consistently over many populations
tested, we used the liberal standard of “any nominal
p < 0.05” to suggest a gene-level replication. To test
whether the OR of the allele associated with altered
gene expression for asthma was significantly greater
or smaller than 1, two-sided P values less than 0.05
were considered significant. SPSS (version 22) was
used for all analyses.
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Results
Search for CHI3L1 eQTLs for a genetic association study
We identified 34 SNPs associated with expression levels
of CHI3L1 mRNA in the lung, six of which had previ-
ously been genotyped in the Tsukuba discovery GWAS
cohort (Table 1; Fig. 1). The genotype frequencies of the
three populations were in Hardy–Weinberg equilibrium.
rs946261 was significantly associated with asthma
The characteristics of the Tsukuba GWAS cohort, the
Tsukuba replication cohort, and the Hokkaido cohort
are shown in Table 2. Among the six eQTLs, the pres-
ence of the C allele at rs946261, which was significantly
associated with reduced expression of CHI3L1 mRNA in
the lung (P = 8.30E-09), was associated with the develop-
ment of asthma (OR 1.27; P = 0.036). We then examined
this association in both the Tsukuba replication cohort
and the Hokkaido cohort. The combined meta-analysis
of the three independent populations showed that the
presence of the loss-of-function C allele was associated
with asthma (OR 1.16; P = 0.013) (Table 3). Rs946261 in
the control groups of the three cohorts did not deviate
from Hardy–Weinberg equilibrium (P > 0.5).
Association of rs946261 with specific phenotypes of
asthma
Figure 2 shows Kaplan–Meier curves for the proportion
of asthma-free individuals versus age of asthma onset for
the three CHI3L1 genotypes (CC, CT, and TT). The
slope of the line for C carriers became steeper at ap-
proximately 40 years of age. Multivariate Cox regression
analysis showed that the HR for the association between
genotypes and risk of asthma was 1.11 (95% CI
1.01–1.21; P = 0.031). On the basis of the results of the
Kaplan–Meier curve, we divided the patients with
asthma into three groups according to age at onset of
the disease (< 21 years, 21–40 years, and > 41 years). The
CHI3L1 genotype was significantly associated with
asthma in patients who developed the disease at an older
age (OR 1.24; 95% CI 1.07–1.45; P = 0.0058). On the
other hand, we found no significant differences in the
CHI3L1 genotype distribution in patients with asthma
who developed the disease at a younger age as compared
with the healthy volunteers (Fig. 3).
We then used multinomial logistic regression analysis
of each of the six clusters to look for an association be-
tween the CHI3L1 genotype and specific asthma pheno-
types. We found a significant association between the
presence of the loss-of-function C allele and cluster A
(OR 1.29; 95% CI 1.03–1.61; P = 0.027), which is charac-
terized by late asthma onset, less atopy, and mild airflow
obstruction (Table 4).
Discussion
In the present study, we conducted a candidate gene
case-control association study of asthma in three
Japanese populations. We focused on CHI3L1 because
YKL-40 has been implicated in the pathogenesis of
asthma [2, 5, 6], and [9] and shown to play a major func-
tional role in inhibiting the inflammasome [3, 4], and
[25]. In addition, we focused on functional SNPs and
studied eQTLs [13, 14]. A meta-analysis of the three in-
dependent Japanese cohorts identified one late-onset
asthma-associated eQTL, rs946261, in the 3′-untrans-
lated region of CHI3L1 (P = 0.0058). The risk allele
rs946261[C] was also associated with a specific adult
asthma cluster that is characterized by later onset, less
atopy, and mild airflow obstruction. This risk allele for
development of late-onset asthma was significantly cor-
related with reduced levels of CHI3L1 expression. Given
that YKL-40 acts as a negative regulator of the inflam-
masome and plays an important role in the process of
inflammation resolution [25], dysregulation of resolution
of inflammation caused by lower expression of YKL-40
in individuals carrying the risk allele may lead to in-
creased susceptibility to development of late-onset
asthma. Changes occur with age in both the innate and
the adaptive immune responses, a phenomenon known
as immunosenescence. Senescent cells do not proliferate
but remain alive and show decreased or altered function.
In the absence of infection, senescent cells show in-
creased, low-grade, basal systemic inflammation (charac-
terized by higher levels of IL-1β, IL-6, and tumor
necrosis factor-α), which is known as inflammaging [26].
Table 1 eQTL SNPs of CHI3L1
SNP Chr1
position
eQTL Minor
allele
Risk
allele
Minor allele frequency Associations with asthma
P value HapMap JPT Tsukuba GWAS cohort
(Nonasthmatic + asthmatic patients)
P value
rs880633 203,183,673 2.5 × 10−9 C T 0.31 0.36 0.30
rs946261 203,188,745 8.3 × 10−9 T C 0.27 0.36 0.036
rs946262 203,189,101 9.9 × 10−13 T T 0.052 0.048 0.94
rs10920579 203,189,844 2.6 × 10−13 A A 0.052 0.048 0.94
rs7541061 203,194,239 6.3 × 10−13 A A 0.052 0.048 0.94
rs946263 203,196,253 2.5 × 10−11 G A 0.023 0.011 0.85
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This inflammaging may partly explain why the genetic
effect of CHI3L1 was especially evident in asthma pa-
tients with disease onset at an older age.
Up to 40% of asthma patients older than 60 years ex-
perienced their first asthma symptoms after 40 years of
age [27]. The underlying airway inflammation in asthma
in adult-onset patients compared with that in
childhood-onset patients is probably different and likely
non-type-2 mediated, and is thus less likely to be suc-
cessfully treated with standard-of-care asthma therapies
[28]. Older asthma patients have more neutrophils in
their sputum than do younger patients [29]. In a sub-
group of patients with asthma and chronic obstructive
pulmonary disease enrolled in a study called BIOAIR in
Europe (Longitudinal Assessment of Clinical Course and
Biomarkers in Severe Chronic Airway Disease), YKL-40
was identified as a steroid-insensitive, non-type-2 bio-
marker related to chronic inflammation [11]. In addition,
an unsupervised cluster analysis of asthma patients pre-
viously identified subgroups according to the YKL-40
level, and the cluster with the highest serum YKL-40
levels was characterized by adult onset and less airflow
obstruction. Airway transcriptome analysis in this cluster
showed activation of non-type-2 inflammatory pathways
[30]. The NLRP3 inflammasome (NLRP3: nucleotide-
binding domain, leucine-rich-containing family, pyrin
domain-containing-3 OR Nod-like receptor protein 3) is
activated in response to a wide range of irritants includ-
ing infectious agents, foreign particles, and endogenous
factors involved in tissue injury and stress. Thus, this
Fig. 1 Pairwise LD (linkage disequilibrium) values (r2 × 100) for the six eQTLs of CHI3L1 were calculated based on the genotypes of the Tsukuba
GWAS cohort. The intensity of the gray shading in the squares of the LD map is proportional to r2
Kanazawa et al. BMC Medical Genetics           (2019) 20:58 Page 5 of 10
inflammasome may play a role in neutrophilic asthma, a
subtype that is commonly induced by respiratory infections,
smoking [31, 32], or obesity [33]. These previous studies to-
gether with the present study support the idea of an import-
ant role for dysregulated activation of the inflammasome in
a specific phenotype of asthma characterized by later-onset,
non-eosinophilic airway inflammation.
In contrast to the current study, the original associ-
ation of CHI3L1 with asthma was found with an in-
creased CHI3L1 mRNA expression. Some other studies
also replicated the association between CHI3L1 eQTL
and asthma but with the risk allele reversed from the
original report [34, 35]. The populations studied in the
original report included one founder population consist-
ing of genetically related individuals and other popula-
tions consisting of many children with asthma [10],
which were totally different from the populations used
in the replication studies consisting of mainly adult pa-
tients with asthma in outbred populations. In the current
study, stronger association was found in adult asthma pa-
tients who developed the disease at 41 years of age or
older, which may indicate that some CHI3L1 SNPs have
an opposite or independent effect on the risk of asthma
later in life as compared with early-onset asthma.
We found no association between rs946261 and
late-onset asthma in the Tsukuba replication cohort, and
the genetic impact of the CHI3L1 genotype on late-onset
asthma was modest as a whole, with possible population
heterogeneity. The current evidence suggests that the
NLRP3 inflammasome and its related cytokines promote
the development of allergic rhinitis [36, 37]. In addition,
house dust mite-induced airway inflammation in mice
significantly enhances the increased inflammasome acti-
vation triggered by rhinovirus infection [38]. Therefore,
the larger number of atopic individuals in the Tsukuba
replication cohort compared with the Tsukuba GWAS
and Hokkaido replication cohorts may obscure the role
of CHI3L1 in the development of asthma in the Tsukuba
replication population. A false-positive result may in-
stead explain the modest association between CHI3L1
and late-onset asthma. This false-positive result may be
due to technical artifacts, heterogeneity in disease
among patients, or an improper cut-off for significance
in the statistical analysis. The efficiency and accuracy of
our genotyping do not support the idea of technical
problems. In addition, all three cohorts consisted of Jap-
anese adults with smoking histories of no more than 10
pack-years. In any case, our finding cannot stand alone
Table 2 Characteristics of the study population
Tsukuba GWAS cohort Tsukuba replication cohort Hokkaido replication cohort
Nonasthmatic
individuals
Asthmatic
patients
Nonasthmatic
individuals
Asthmatic
patients
Nonasthmatic
individuals
Asthmatic
patients
Number of participants 734 237 375 381 554 428
Sex (female, %) 499 (68.0) 142 (59.9) 251 (66.9) 276 (72.4) 314 (56.7) 295 (68.9)
Age, y (range) 49.3 (27–74) 51.4 (20–75) 49.5 (22–78) 59.0 (19–100) 43.5 (18–84) 49.5 (16–83)
Age of asthma onset (range) 37.9 (0–70) 41.4 (1–88) 34.0 (0–80)
Smoking (%)
Pack-year 0 607 (82.7) 196 (82.7) 311 (82.9) 313 (82.2) 492 (88.8) 331 (77.3)
0–10 127 (17.3) 41 (17.3) 64 (17.1) 68 (17.8) 62 (11.2) 97 (22.7)
Atopy (%) 412 (56.1) 151 (63.7) 257 (68.5) 175 (72.6) 304 (55.1) 300 (70.8)
FEV1% pred. (%, SD) 94.6 (12.3) 89.9 (20.1) 89.3 (14.1) 84.4 (23.2) 106.7 (14.5) 85.2 (23.8)
Serum IgE (log, SD) 1.68 (0.55) 2.22 (0.61) 1.90 (0.64) 2.18 (0.66) 1.80 (0.63) 2.27 (0.67)
Information on atopy, FEV1%pred., and serum IgE was missing in 27, 5, and 20 patients with asthma in the Tsukuba GWAS cohort, respectively
Information on FEV1%pred., was missing in 5 nonasthmatic controls in the Tsukuba replication cohort
Information on atopy, FEV1% pred., and serum IgE was missing in 140, 39, and 87 patients with asthma in the Tsukuba replication cohort, respectively
Information on atopy, FEV1% pred., and serum IgE was missing in 2, 170, and 11 nonasthmatic controls in the Hokkaido cohort, respectively
Information on atopy, FEV1% pred., and serum IgE was missing in 4, 48, and 4 patients with asthma in the Hokkaido cohort, respectively
Table 3 Results of association analysis in the three populations for rs946261
Tsukuba GWAS cohort Tsukuba replication cohort Hokkaido replication cohort Meta-analysis
n RAF OR P value n RAF OR P value n RAF OR P value OR P value
(C) (95% CI) (C) (95% CI) (C) (95% CI) (95% CI)
Asthmatic patients 237 0.68 1.27 0.036 381 0.64 1.00 0.97 428 0.67 1.23 0.032 1.16 0.013
Nonasthmatic individuals 734 0.63 (1.02–1.59) 375 0.64 (0.81–1.23) 554 0.62 (1.02–1.48) (1.03–1.31)
RAF Risk allele frequency
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but should be seen as a contribution to the discussion
about the genetic role of CHI3L1 in asthma. Future
studies are necessary and should involve sufficiently
powered cohorts of asthma patients and subgrouping
by disease phenotype to further understand how gen-
etic variations in CHI3L1 affect the risk for late-onset
adult asthma.
Conclusions
In conclusion, the loss-of-function CHI3L1 genotype
was specifically associated with late-onset asthma that
developed at the age of 40 years or older. A previous
study described different asthma endotypes, such as in-
creased susceptibility to viral infections, increased bac-
terial colonization, abnormal lung development, and
Fig. 2 Kaplan–Meier curves for the proportions of asthma-free individuals. The P value for the association between genotype and the risk of
asthma was 0.031 with multivariate Cox regression analysis
Fig. 3 ORs for association between rs946261 and asthma in the three groups according to age at onset of the disease
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increased type-2 inflammation [39]. Given the import-
ant role of YKL-40 in many pathophysiologic pro-
cesses, including cell growth, migration, chemotaxis,
reorganization, and tissue remodeling, altered expres-
sion of YKL-40 may be involved in an important
pathogenic role in the establishment of airway inflam-
mation and remodeling, especially in specific pheno-
type(s) of asthma. Increased knowledge regarding the
pathophysiologic role of YKL-40 in late-onset adult
asthma will suggest new strategies for treating pa-
tients with specific endotypes early during the disease
course, as specified by biomarkers or treatable charac-
teristics of each endotype.
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